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ABSTRACT	
Introduction	
Slovenia	has	a	high	burden	of	head	and	neck	cancer.	Patients	are	mostly	treated	with	
surgery	followed	by	radiation	therapy.	Advanced	surgical	and	prosthodontic	techniques	have	
expanded	the	rehabilitation	options.	The	aim	of	the	study	was	to	review	the	outcome	of	
implant-prosthetic	treatment	after	radiation	therapy.	
Materials	and	methods:		
20	irradiated	head	and	neck	cancer	patients	who	received	a	removable	implant-supported	
denture	at	the	University	Medical	Centre	Ljubljana	were	included	in	the	study.	Kaplan-Meier	
survival	analysis,	Cox	proportional	hazard	models	and	logistic	regression	were	used	to	assess	
the	implant	survival	and	success	rate.	
Results:		
20	patients	had	100	implants	inserted.	The	estimated	survival	rate	was	96%	after	1	year	and	
87%	after	5	years.	Failures	were	mostly	observed	before	loading	(91.2%).	Implants	inserted	
in	the	transplanted	bone	were	significantly	more	likely	to	fail.	Out	of	89	implants	supporting	
the	dentures,	79	implants	(88.7%)	were	successful,	meaning	that	they	were	functionally	
loaded	and	exhibited	no	pain,	radiolucency	or	progressive	bone	loss.	Prosthetic	treatment	
was	significanly	less	successful	in	older	patients.	The	attachment	system	and	the	number	of	
the	denture	did	not	have	a	statistically	significant	influence	on	the	success	rate.		
Conclusions:		
Implant-supported	dentures	proved	to	be	a	reliable	treatment	modality	after	head	and	neck	
cancer	surgery	and	radiation	therapy.	Possible	early	failures	should	be	communicated	with	
the	patients.	
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Izid	implantatno-protetične	rehabilitacije	po	obsevanju	zaradi	raka	glave	in	vratu	
POVZETEK	
Uvod:	
V	Sloveniji	je	visoka	pojavnost	raka	glave	in	vratu.	Zdravljenje	najpogosteje	vključuje	
kombinacijo	kirurške	obravnave	in	obsevanja.	Možnosti	kasnejše	protetične	rehabilitacije	so	
izboljšane	ob	uporabi	sodobnih	kirurških	tehnik	in	zobnih	vsadkov.	Namen	prispevka	je	
prikazati	izid	implantatno-protetične	oskrbe	obsevanih	pacientov	na	Univerzitetnem	
kliničnem	centru	Ljubljana.		
Metode	in	materiali:	
V	študiji	smo	preverili	izid	zdravljenja	20	pacientov	po	kirurški	oskrbi	in		obsevanju	zaradi	
raka	glave	in	vratu,	ki	smo	jih	oskrbeli	z	implantatno	podprtimi	protezami.	Preživetje	in	
uspešnost	zobnih	vsadkov	smo	statistično	ovrednotili	z	metodo	Kaplan-Meier,	Coxovimi	
modeli	sorazmernih	tveganj	in	logistično	regresijo.		
Rezultati:		
20	pacientov	je	skupno	prejelo	100	zobnih	vsadkov.	Ocenjena	stopnja	preživetja	vsadkov	je	
bila	96%	po	1	letu	in	87%	po	5	letih.	Do	odpovedi	vsadkov	je	večinoma	prišlo	pred	
obremenitvijo	(91.2%).	Vsadki	v	presajeni	kosti	so	imeli	statistično	značilno	slabše	preživetje.	
Izmed	89	obremenjenih	vsadkov	jih	je	bilo	79	(88.7%)	uspešnih,	kar	je	pomenilo	
funkcionalno	uporabo	protez	in	odsotnost	bolečin	ali	napredujoče	izgube	kostnine.	Opazili	
smo	statistično	značilno	slabšanje	uspeha	z	napredujočo	starostjo,	medtem	ko	izbor	
protetičnega	sidra	in	število	vsadkov	pod	protezo	in	na	uspeh	rehabilitacije	nista	imela	
statistično	značilnega	vpliva.	
Zaključki:	
5	
	
Implantatno	podprte	proteze	so	zanesljiv	način	protetične	oskrbe	po	obsevanju	zaradi	raka	
glave	in	vratu.	Paciente	je	potrebno	seznaniti	z	možnostjo	zgodnje	odpovedi	vsadkov.	
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INTRODUCTION	
	
Slovenia	is	among	the	countries	with	the	highest	incidence	of	oral	and	oropharyngeal	cancer	
(de	Camargo	Cancela,	2010	and	2012).	In	a	populaton	of	2	million	people,	approximately	450	
cases	are	diagnosed	per	year	(Cancer	in	Slovenia	2011,	2015).	Most	tumors	are	regionally	
advanced	and	the	patients	are	treated	with	radical	resection	and	reconstruction	followed	by	
radiation	treatment	(Cancer	in	Slovenia	2011,	2015).	Afterwards,	patients	experience	
profound	changes	in	the	oral	anatomy,	function	and	facial	appearance.	Radiation	treatment	
causes	irreversible	damage	to	both	hard	and	soft	tissues	by	creating	a	hypoxic,	hypocellular	
and	hypovascular	environment	which	impedes	wound	healing	and	creates	a	risk	for	
osteoradionecrosis	(Marx,	1983).	A	protocol	involving	hyperbaric	oxygen	treatment	(HBO)	
was	proposed	as	a	method	to	enhance	wound	healing	by	increasing	the	tissue	oxygenation	
(Larsen,	1997).	
Following	the	radical	procedures	to	eradicate	cancer,	the	greatest	problems	perceived	by	
irradiated	patients	are	swallowing,	mouth	opening,	xerostomia	and	compromised	aeshetics	
(Fierz,	2013).	Prosthodontic	treatment	is	advocated	to	regain	lost	oral	functions,	enhance	
the	physical	appearance	and	enable	the	patient	to	take	part	in	normal	daily	activities	with	
greater	confidence.	However,	comprehensive	prosthetic	treatment	after	head	and	neck	
cancer	is	challenging,	time-consuming	and	costly.	Therefore,	only	40%	of	such	patients	are	
treated	following	the	postsurgical	prosthetic	protocol.	Among	them,	70%	receive	dentures	
supported	by	the	residual	teeth	and	bone	and	30%	receive	implant-supported	dentures	
(Brauner,	2010).	Edentulous	patients	with	head	and	neck	cancer	after	radiation	therapy	are	
an	especially	vulnerable	subgroup.	Radiation	treatment	sequelae	persist	throughout	the	
patient’s	lifetime	and	in	the	past,	radiation	therapy	used	to	be	an	absolute	contraindication	
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to	placing	of	dental	implants	(Carini,	2012).	Treatment	options	have	therefore	been	limited	
to	conventional	complete	dentures	or	no	prosthetic	rehabilitation	at	all.		
Advanced	surgical	surgical	and	prosthodontic	techniques,	such	as	3D	planning	and	guided	
implant	surgery,	have	expanded	the	treatment	options	(Schiegnitz,	2014).	In	addition	to	
conventional	ball-	and	bar-retained	dentures,	new	attachments	have	been	introduced	to	
clinical	practice.	Locator	attachment	is	commonly	used	in	removable	implant	
prosthodontics.	It	is	a	self-aligning	system	with	relatively	simple	maintenance	requirements	
(Andreiotelli,	2010).	Locator	is,	however,	a	non-rigid	type	of	attachment	and	does	not	
completely	relieve	the	stress	from	the	underlying	mucosa.	To	address	this	issue,	technically	
more	advanced	system	of	prefabricated	double	crowns	on	implants	has	been	introduced	
(May,	2002).	The	SynCone	system	(Dentsply,	Germany)	is	indicated	in	unfavourable	
resection	areas,	where	completely	rigid	constructions	are	necessary	due	to	the	anatomical	
constraints.	Both	Locator	and	Syncone	systems	are	commonly	used	at	the	University	Medical	
Centre	Ljubljana,	Slovenia.	These	attachment	systems	have	expanded	the	treatment	
possibilities	for	the	rehabilitation	of	head	and	neck	cancer	patients,	which	is	always	a	
collaborative	work	between	oral	surgeons	and	prosthodontists.		
The	aim	of	the	study	was	to	review	the	outcome	of	the	implant-prosthetic	rehabilitation	of	
irradiated	patients	performed	at	the	University	Medical	Centre	Ljubljana.	
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MATERIALS	AND	METHODS	
A	retrospective	chart	review	was	performed	for	the	patients	who	were	treated	jointly	by	the	
Department	of	oral	and	maxillofacial	surgery	and	the	Department	of	prosthodontics	at	the	
University	Medical	Centre	Ljubljana	in	the	time	period	from	2008	to	2014.	Only	patients	who	
underwent	resection	of	malignant	tumours	with	a	subsequent	radiation	treatment	and	
received	removable	implant-supported	dentures	were	included	in	the	study.	The	recorded	
data	included	patient	gender	and	date	of	birth,	smoking	status	at	the	time	of	prosthetic	
rehabilitation,	cancer	type,	surgical	management,	date	and	dose	of	radiation	treatment,	
administration	of	hyperbaric	oxygen	treatment	(HBO),	timing	to	implant	surgery	and	to	
functional	loading,	treated	jaw,	type	of	implant	bed,	number	of	implants	supporting	the	
dentures,	implant	system	and	the	denture	attachment	system	used.	At	University	Medical	
Centre	Ljubljana,	HBO	is	provided	according	to	the	protocol	suggested	by	Marx	and	Larsen	
(Marx	1983,	Larsen	1997).	Patients	are	scheduled	for	20	sessions	before	and	10	sessions	
after	the	implant	insertion,	respectively.	Each	90-minute	session	consists	of	exposure	to	
100%	oxygen	on	2.5	ATA	(1.5	bar)	with	three	breaks	during	which	patients	breathe	normal	
air.	
The	implants	were	assessed	for	survival	and	success	using	the	guidelines	proposed	by	van	
Steenberghe	et	al	(1997).	The	survival	criteria	included	osseointegration	and	presence	in	the	
mouth.	To	be	considered	successful,	the	implant	had	to	be	functionally	loaded,	immobile,	
without	persistent	pain	or	inflammation	of	the	periimplant	tissue	and	without	progressive	
bone	loss	evident	from	radiographs	and	probing	depth	at	yearly	recall.		
The	survival	time	was	measured	from	the	date	of	the	implant	insertion	to	the	date	of	the	
implant	failure	or	the	last	control	of	the	implant.		
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The	present	series	consisted	of	20	patients	(11	men	and	9	women)	with	a	median	age	of	57.6	
years	(range	46.7	to	77.2	years)	at	the	time	of	the	implant	insertion.	17	patients	(85%)	had	a	
history	of	squamous	cell	carcinoma.	Mucoepidermoid,	adenoid	cystic	and	origo	ignota	
metastatic	cancer	were	diagnosed	in	1	patient	each.	The	most	common	sites	of	primary	
cancer	were	the	tongue	and	the	floor	of	the	mouth	(6	patients	each),	followed	by	pharynx	
and	maxilla	(2	patients	each).	Mandible,	tonsilla,	larynx	and	origo	ignota	metastases	in	
lymph	nodes	were	encountered	in	one	patient	each.	A	segmental	resection	of	the	mandible	
was	performed	in	8	patients.	In	one	patient,	the	tumor	resection	in	the	maxilla	resulted	in	an	
oronasal	communication.	After	surgery,	all	patients	were	subjected	to	the	radiation	therapy,	
with	reported	doses	ranging	from	54	to	66	Gy.		
Reconstruction	with	bone	and	soft	tissue	grafts	was	accomplished	in	3	patients.	In	two	cases	
the	fibular	graft	was	used	to	reconstruct	the	mandible.	In	one	patient	the	maxilla	was	
reconstructed	with	the	iliac	crest	bone	graft.			
The	Kaplan-Meier	method	was	utilized	to	estimate	the	implant	survival	rate.	The	association	
between	the	survival	and	the	potential	prognostic	factors	was	analyzed	by	fitting	univariate	
Cox	proportional	hazards	models.	The	association	between	the	potential	prognostic	factors	
and	implant	success	was	analyzed	with	univariate	logistic	regression	models.	The	Holm-
Bonferroni	method	was	used	to	account	for	multiple	comparisons	and	the	level	of	
significance	was	set	to	α=0.05.	Statistical	analyses	were	conducted	with	the	statistical	
software	package	R	[R].	
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RESULTS	
As	presented	in	Table	1,	100	implants	of	3	different	implant	systems	were	included	in	the	
study:	18	Astra	Tech	implants	(Dentsply,	Mannheim,	Germany),	22	Straumann	implants	
(Institut	Straumann	AG,	Basel,	Switzerland)	and	60	Ankylos	implants	(Dentsply,	Mannheim,	
Germany).	28	implants	were	inserted	in	the	maxilla	and	72	in	the	mandible.	92	implants	
were	inserted	in	native	bone	and	8	in	transplanted	bone.	The	median	time	between	the	end	
of	the	radiation	therapy	and	the	implant	surgery	was	3.8	years	(range	1.1	to	38.1	years).	
Prophylactic	antibiotic	therapy	was	prescribed	to	all	patients	and	HBO	was	administered	to	
16	patients.	Osteoradionecrosis	was	not	observed	in	this	study.	All	implants	were	inserted	in	
edentulous	jaws,	with	5	patients	receiving	implants	in	both	jaws,	14	only	in	the	mandible	
and	1	only	in	the	maxilla.	12	patients	were	non-smokers	and	8	patients	were	smokers	at	the	
time	of	the	prosthetic	rehabilitation.	A	two-stage	implant	insertion	protocol	was	used	in	all	
cases.	The	median	healing	period	between	the	implant	insertion	and	functional	loading	was	
15.1	months	(range	4.3	to	54.3	months).	As	shown	in	Table	2,	three	different	attachment	
systems	for	implant-supported	dentures	were	used:	39	Locator	attachments	(Zest	Anchors,	
Escondido,	USA)	(Figure	1),	40	prefabricated	conical	crowns	(SynCone,	Dentsply	Friadent,	
Mannheim,	Germany)	(Figure	2),	and	10	custom	designed	bar-clip	systems.		
Median	follow	up	after	implant	insertion	was	61.9	months	(range	1.4	to	90.2	months).		
The	Kaplan-Meier	estimated	1-	and	5-year	cumulative	implant	survival	rates	were	96%	(95%	
confidence	interval:	92.2%-99.9%)	and	87.0%	(95%	confidence	interval:	80.4-94.2%).	The	
survival	curve	is	shown	on	Figure	3.	During	the	examination	period,	three	patients	died.	Time	
of	these	14	implants'	service	in	the	mouth	was,	as	with	other	implants,	registered	from	the	
date	of	the	implant	insertion	to	the	date	of	the	last	follow-up	examination.	
The	median	time	of	failure	was	19.1	months	(range	1.4	to	48.5	months)	after	implantation.		
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The	crude	survival	rate	in	our	sample	was	88%,	as	12	implants	in	5	patients	failed.	Data	for	
all	the	implants	and	for	the	subgroups	of	survived	and	failed	implants	are	described	in	Table	
1.	Primary	implant	failure	during	the	healing	period	before	functional	loading	was	recorded	
in	11	implants	(91.2%).	The	causes	of	implant	removal	in	our	sample	were	incomplete	
osseointegration	(4),	persistent	pain	(4),	and	periimplantitis	with	recurrent	soft	tissue	
hyperplasia	(3).	The	only	implant	that	was	lost	after	functional	loading	(secondary	implant	
failure)	was	included	in	a	bar-supported	denture	and	had	to	be	removed	because	of	
periimplantitis.	
Results	of	the	analysis	with	the	Cox	regression	models	is	presented	in	Table	2.	The	survived	
and	failed	implants	were	comparable	considering	the	patient’s	gender,	age	and	smoking	
status,	the	time	elapsed	between	the	radiation	therapy	and	the	implant	surgery,	the	jaw	of	
the	implant	insertion	and	the	administration	of	HBO.	The	results	for	the	bone	type	indicated	
that	the	implants	inserted	in	the	transplanted	bone	were	statistically	significantly	more	likely	
to	fail	than	those	inserted	in	the	native	bone.	The	influence	of	the	implant	system	on	the	
survival	could	not	be	analyzed	because	of	the	insufficient	number	of	failure	events	among	
the	three	groups.	
As	presented	in	Table	3,	89	implants	were	observed	after	functional	loading.	79	of	those	
implants	(88.7%)	were	successful,	meaning	that	they	were	functionally	loaded	and	exhibited	
no	pain,	radiolucency	or	progressive	bone	loss	evident	from	radiographs	and	probing	depth	
at	yearly	recall.	Regardless	of	the	appropriate	osseointegration,	prosthetic	rehabilitation	of	
10	implants	(11.2%)	in	four	patients	(20%)	did	not	have	a	favourable	outcome.	Two	patients	
with	4	implants	experienced	difficulties	in	adapting	to	dentures	and	did	not	wear	them	on	
regular	basis.	In	addition,	two	further	implants	were	considered	unsuccessful	because	of	
persistent	soft	tissue	discomfort	reported	by	the	patients.	As	shown	in	Table	3,	higher	
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patient	age	was	a	statistically	significant	predictor	for	the	lack	of	success.	Gender,	smoking	
status,	healing	time	after	implant	insertion,	the	number	of	implants	supporting	the	denture,	
the	prosthetic	system,	jaw,	bone	type	and	administered	HBO	did	not	have	a	statistically	
significant	effect	on	the	success	rate	of	loaded	implants	in	this	sample	of	irradiated	patients.
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DISCUSSION	
It	has	been	shown	in	this	study	that	the	implant-supported	denture	is	a	reliable	treatment	
modality	for	the	head	and	neck	cancer	patients	that	undergo	radiation	therapy.	When	
special	surgical	and	prosthodontic	protocols	are	conducted	appropriately,	dental	implants	
greatly	enhance	the	stability	of	the	dentures	and	improve	the	facial	contours.	According	to	
the	current	guidelines,	very	few	absolute	contraindications	exist	for	using	dental	implants	in	
medically	compromised	patients	(Diz,	2013).	Radiation	therapy	in	the	head	and	neck	region	
is	no	longer	a	contraindication,	as	there	is	a	growing	number	of	reports	that	a	high	
osseointegration	rate	and	a	predictable	treatment	outcome	can	be	expected	(Ihde,	2009,	
Tanaka,	2013).	When	considering	the	prosthodontic	rehabilitation	options,	the	socio-
economic	status	of	the	patients	should	be	evaluated	carefully.	As	head	and	neck	cancer	is	
connected	with	smoking	and	alcohol	overconsumption,	similar	problems	can	persist	after	
the	initial	cancer	treatment,	jeopardizing	the	implant-prosthetic	rehabilitation	outcome.	
In	this	case	series	of	irradiated	patients,	the	implant	failures	were	rare	and	mostly	confined	
to	the	healing	period.	The	predominantly	early	implant	loss	is	in	accordance	with	the	
findings	of	Linsen	et	al	(2012).	Extended	healing	time	should	therefore	be	allowed	after	
implantation	and	immediate	loading	protocols	are	not	advised	(Diz,	2013).	
The	Kaplan-Meier	estimated	1-	and	5-year	cumulative	implant	survival	rates	were	96%	and	
87%.	This	is	in	accordance	with	Buddula	et	al	(2012)	reporting	implant	survival	rates	of	98.9%	
and	89.9%	after	1	and	5	years	and	Yerit	et	al	(2006)	reporting	a	95%	and	91%	survival	after	2	
and	5	years,	respectively.	Due	to	the	small	number	of	failed	implants,	detailed	statistical	
analysis	of	prognostic	factors	for	implant	failure	is	often	not	possible	or	lacks	power.	It	is	
therefore	difficult	to	draw	meaningful	conclusions	from	the	results	of	single	studies	alone.	In	
this	study,	some	limited	insight	could	be	obtained	regarding	the	survival	of	implants.	There	
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was	a	statistically	significant	higher	failure	rate	in	the	transplanted	bone.	The	reduced	
survival	of	implants	in	the	transplanted	bone	may	be	explained	by	differences	in	bone	
quality,	bone	volume,	and	revascularization	compared	to	the	native	bone	(Schiegnitz,	2014).	
Our	findings	are	in	agreement	with	Yerit	et	al	(2006),	where	lower	survival	was	also	reported	
for	the	transplanted	bone.	In	contrast,	Buddula	et	al	(2012)	reported	no	difference	between	
implant	survival	in	the	native	and	transplanted	bone.	They	also	reported	no	difference	in	
survival	between	genders	and	considering	the	time	span	between	radiation	treatment	and	
implant	insertion,	which	is	in	accordance	with	this	study.	Their	finding	of	the	statistically	
significant	higher	hazard	ratio	for	implants	in	the	upper	jaw	could	not	be	confirmed	in	this	
study.	While	the	risk	for	implant	failure	is	known	to	be	slightly	greater	in	smoking	patients	
(DeLuca	2006),	the	smoking	status	was	not	a	detectable	predictor	for	the	implant	survival	in	
this	study.	This	was	also	true	for	HBO,	which	is	commonly	used	at	the	University	Medical	
Centre	Ljubljana	for	the	head	and	neck	cancer	patients	requiring	surgery.	Generally,	there	is	
no	agreement	on	the	HBO	efficacy	and	value	(Spiegelberg,	2010).		
Implant	osseointegration	and	survival	data	provide	valuable	information	about	the	success	
of	the	implant	therapy.	Nevertheless,	the	final	judgement	of	the	implant-prosthetic	therapy	
should	be	made	according	tho	the	denture	performance	in	the	oral	cavity.	Successful	
implants	enable	the	patients	to	use	the	dentures	and	do	not	cause	any	persistent	
discomfort.	To	achieve	a	favorable	clinical	outcome,	it	is	crucial	to	design	a	viable	prosthetic	
plan	early	in	the	rehabilitation	process.	Head	and	neck	cancer	patients	present	severely	
altered	and	unfavourable	tissue	conditions,	making	it	challenging	to	model	rehabilitation	
using	the	optimal	top-down	approach.	The	fragile	mucosa,	xerostomia,	limited	mouth	
opening	and	jaw	deviations	are	additional	factors	to	consider.	The	possible	locations,	
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angulations	and	implant	dimensions	might	not	be	ideal	and	should	be	discussed	thoroughly	
between	the	oral	surgeon	and	the	prosthodontist.		
The	optimal	number	of	implants	should	be	carefully	decided.	There	is	a	tendency	to	insert	as	
few	implants	as	possible	in	oncological	patients,	to	facilitate	bone	healing.	On	the	other	
hand	a	greater	number	is	often	required	to	design	rigid,	implant-borne	prosthetic	
constructions	(Diz,	2013).	More	implants	also	allow	more	flexibility	in	prosthetic	treatment	
planning.	Moreover,	if	some	implants	are	lost,	implant	dentures	can	be	successfully	repaired	
and	worn	by	the	patients.	It	is	currently	thought	that	the	number	of	implants	is	not	critical	
for	the	success	of	the	prosthetic	treatment	(Roccuzzo,	2012),	but	long-term	clinical	studies	
are	lacking.	In	the	present	study	the	number	of	implants	supporting	the	dentures	was	not	a	
detectable	factor	in	the	success	rate	of	the	prosthodontic	rehabilitation.	Similarly,	neither	
was	the	treated	jaw	or	the	healing	time,	which	exceeded	4	months	in	all	implants.		
The	loaded	implants	also	exhibited	similar	success	rates	regardless	of	the	denture	
attachment	system	used.	While	the	bar-supporting	implants	experienced	less	success,	the	
differences	in	comparison	to	the	Locator	attachments	and	SynCone	systems	were	not	
significant.		
Additional	systemic	and	patient-related	factors	might	play	an	important	role	in	implant	
prosthetic	rehabilitation.	In	this	case	series	of	irradiated	patients,	advanced	age	showed	a	
negative	prognostic	value	for	the	rehabilitation	success,	but	not	for	implant	survival.	One	of	
the	possible	limitations	of	this	study	was	that	the	data	on	systemic	diseases	and	alcohol	
consumption	which	might	negatively	affect	implant	performance	were	not	included.	After	
completion	of	the	implant-prosthetic	rehabilitation,	it	is	of	utmost	importance	to	enrol	the	
patient	in	an	appropriate	supportive	program,	with	regular	recalls,	cancer	screening	and	
maintenance	of	the	peri-implant	conditions.	The	recall	program	should	meet	the	individual	
16	
	
needs	of	the	patients	according	to	the	overall	risk	profile.	Some	patients	should	be	recalled	
every	3	months,	while	others	may	need	to	be	checked	once	per	year	(Lang	2015).	
This	study	has	shown	that	favorable	rehabilitation	results	can	be	obtained	with	implant-
prosthetic	treatment	in	irradiated	patients.	With	proper	collaboration	between	experienced	
surgeons	and	prosthodontists,	this	treatment	modality	can	be	regarded	a	viable	option	for	
oral	rehabilitation	after	head	and	neck	cancer.	
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TABLES	
Table	1	
Summary	of	the	implant	survival	according	to	the	factors	of	interest.	
	
Parameter	 All	implants	
(n=100)	
Survived	implants	
(n=88)	
Failed	implants	
(n=12)	
Patient’s	median	age	at	
implant	insertion	in	years	
(range)	
58.3	
(46.7-77.2)	
61.5	
(46.7-77.2)	
57.9	
(46.7-77.2)	
Median	time	interval	
between	radiation	
treatment	and	implant	
insertion	in	years	
(range)	
3.8	
(1.1-38.1)	
3.2	
(1.1-38.1)	
5.2	
(2.4-12.8)	
Patient’s	gender		
• Female,	n	(%)	
• Male,	n	(%)	
	
40	(40%)	
60	(60%)	
	
32	(36%)	
56	(64%)	
	
8	(67%)	
4	(33%)	
Smoking	
• No,	n	(%)	
• Yes,	n	(%)	
	
66	(66%)	
34	(34%)	
	
57	(65%)	
31	(35%)	
	
9	(75%)	
3	(25%)	
Implant	system	
• Astra,	n	(%)		
• Straumann,	n	(%)	
• Ankylos,	n	(%)	
	
18	(18%)	
22	(22%)	
60	(60%)	
	
18	(20%)	
17	(20%)	
53	(60%)	
	
0	(0%)	
5	(42%)	
7	(58%)	
Jaw		
• Lower,	n	(%)	
• Upper,	n	(%)	
	
72	(72%)	
28	(28%)	
	
63	(72%)	
25	(28%)	
	
9	(75%)	
3	(25%)	
Bone		
• Native,	n	(%)	
• Transplanted,	n	(%)	
	
92	(92%)	
8	(8%)	
	
85	(97%)	
3	(3%)	
	
7	(58%)	
5	(42%)	
HBO	administred	
• No,	n	(%)	
• Yes,	n	(%)	
	
19	(19%)	
81	(81%)	
	
14	(16%)	
74	(84%)	
	
5	(42%)	
7	(58%)	
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Table	2	
	
Predictors	of	the	implant	failure.		
	
Parameter	 Hazard	ratio	
(95%	confidence	interval)	
p	
	
Patient’s	age	at	implant	
insertion	in	years	
1.05		
(0.99-1.12)	
1.0000	
Time	interval	between	
the	radiation	treatment	
and	the	implant	
insertion	in	years	
0.99		
(0.92-1.07)	
1.0000	
Female	gender	 2.74		
(0.82-9.10)	
1.0000	
Smoker	 0.72	
(0.19-2.66)	
1.0000	
Lower	jaw	 0.84		
(0.23-3.09)	
1.0000	
Transplanted	bone	 12.37		
(3.87-39.56)	
0.0003	
HBO	administered	
	
0.31		
(0.10-0.98)	
0.4753	
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Table	3	
	
Summary	of	the	loaded	implants’	success	according	to	the	factors	of	interest.		
	
Parameter	 All	loaded	
implants	
(n=89)	
Successful	loaded	
implants	
(n=79)	
Unsuccessful	
loaded	
implants	
(n=10)	
Median	patient’s	age	at	
prosthetic	rehabilitation	
in	years	
(range)	
	
59.1	
(49.3-79.2)	
	
58.9	
(49.3-67.9)	
	
71.7	
(59.1-79.2)	
Median	healing	time	
after	the	implant	
insertion	in	months	
(range)	
	
15.1	
(4.3-54.4)	
	
15.2	
(4.3-54.4)	
	
13.0	
(4.3-24.6)	
Patient’s	gender		
• Female,	n	(%)	
• Male,	n	(%)	
	
33	(37%)	
56	(63%)	
	
25	(32%)	
54	(68%)	
	
8	(80%)	
2	(20%)	
Smoking	
• No,	n	(%)	
• Yes,	n	(%)	
	
57	(64%)	
32	(36%)	
	
49	(62%)	
30	(38%)	
	
8	(80%)	
2	(20%)	
Median	number	of	the	
implants	supporting	the	
denture	
(range)	
	
4	(2-5)	
	
4	(2-5)	
	
4	
Implant	denture	system	
• Bar,	n	(%)	
• Locator,	n	(%)	
• SynCone,	n	(%)	
	
10	(11%)	
39	(44%)	
40	(45%)	
	
6	(8%)	
37	(47%)	
36	(45%)	
	
4	(40%)	
2	(20%)	
4	(40%)	
Jaw		
• Upper,	n	(%)	
• Lower,	n	(%)	
	
25	(28%)	
64	(72%)	
	
21	(27%)	
58	(73%)	
	
4	(40%)	
6	(60%)	
Bone		
• Native,	n	(%)	
• Transplanted,	n	
(%)	
	
86	(97%)	
3	(3%)	
	
76	(96%)	
3	(4%)	
	
10	(100%)	
0	(0%)	
HBO	administred	
• Yes	
• No	
	
75	(84%)	
14	(16%)	
	
65	(82%)	
14	(18%)	
	
10	(100%)	
0	(0%)	
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Table	4	
	
Predictors	of	the	loaded	implants’	success.	
	
Parameter	 Odds	ratio	for	the	loaded	implants’	success	
(95%	confidence	interval)	
p	
	
Patient’s	age	at	prosthetic	
rehabilitation	
0.66		
(0.49-0.80)	
0.0075	
Healing	time	after	the	
implant	insertion	
1.09		
(0.53-2.73)	
1.0000	
Male	gender	 8.64		
(1.99-60.09)	
0.1456	
Smoker	 2.44	
(0.57-16.95)	
1.0000	
Number	of	the	implants	
supporting	the	denture	
0.78		
(0.24-1.94)	
1.0000	
Denture	attachment	system	
• Locator	vs	bar	
	
• SynCone	vs	bar	
	
• SynCone	vs	Locator	
	
12.33		
(1.98-104.98)	
6.00		
(1.15-32.68)	
0.48	
(0.06-2.65)	
	
0.1456	
	
0.4416	
	
1.0000	
Upper	jaw		
	
0.54		
(0.14-2.30)	
1.0000	
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Figures	
	
Figure	1	
	
A	clinical	situation	of	a	patient	with	the	segmental	resection	of	the	left	mandible	body	due	to	
cancer,	as	visible	on	the	radiograph	(a).	The	patient	received	an	implant-supported	lower	
denture	(b),	where	the	retention	was	based	on	the	Locator	concept	(c).	
	 	
b	
c	
a	
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Figure	2	
	
A	clinical	situation	of	a	patient	rehabilitated	after	oropharyngeal	carcinoma.	Segmental	
resection	of	the	left	mandible	body	is	visible	on	the	radiograph	(a).	The	patient	received	
implant-supported	lower	and	upper	dentures	with	retention	based	on	the	SynCone	double	
crown	concept	(b).	
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Figure	3	
	
The	Kaplan-Meier	curve	for	the	survival	of	the	implants.	95%	confidence	intervals	and	
censored	data	are	included	on	the	plot.	
	
	
	
	
	
	
	
